INTRATHECAL GENE THERAPY IN A NEUROPATHY MODEL EXPRESSING A CMT1X MUTATION

被引：0
|
作者：
Kagiava, A. [1 ]
Karaiskos, C. [1 ]
Richter, J. [2 ]
Sargiannidou, I [1 ]
Christodoulou, C. [2 ]
Kleopa, K. A. [1 ,3 ]
机构：
[1] Cyprus Inst Neurol & Genet, Cyprus Sch Mol Med, Neurosci Lab, Nicosia, Cyprus
[2] Cyprus Inst Neurol & Genet, Cyprus Sch Mol Med, Dept Mol Virol, Nicosia, Cyprus
[3] Cyprus Inst Neurol & Genet, Cyprus Sch Mol Med, Neurol Clin, Nicosia, Cyprus
来源：
JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM | 2016年 / 21卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：268 / 268
页数：1
相关论文
共 50 条
  • [1] Intrathecal gene therapy in mouse models expressing CMT1X mutations
    Kagiava, A.
    Karaiskos, C.
    Richter, J.
    Tryfonos, C.
    Lapathitis, G.
    Sargiannidou, I.
    Christodoulou, C.
    Kleopa, K. A.
    HUMAN MOLECULAR GENETICS, 2018, 27 (08) : 1460 - 1473
  • [2] Gene replacement therapy for CMT1X neuropathy
    Kagiava, Alexia
    Richter, Jan
    Tryfonos, Christina
    Karaiskos, Christos
    Sargiannidou, Irene
    Christodoulou, Christina
    Kleopa, Kleopas
    JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2018, 23 (04) : 332 - 332
  • [3] INTRATHECAL GENE THERAPY IN DIFFERENT MUTANT MOUSE MODELS OF CMT1X
    Kagiava, A.
    Karaiskos, C.
    Richter, J.
    Tryfonos, C.
    Lapathitis, G.
    Sargiannidou, I
    Christodoulou, C.
    Kleopa, K. A.
    JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2017, 22 (03) : 310 - 311
  • [4] Gene therapy after onset of neuropathy provides therapeutic benefit in a model of CMT1X
    Kleopa, Kleopas
    Karaiskos, Christos
    Richter, Jan
    Tryfonos, Christina
    Rossor, Alexander
    Reilly, Mary
    Sargiannidou, Irene
    Christodoulou, Christina
    Kagiava, Alexia
    NEUROLOGY, 2019, 92 (15)
  • [5] Gene replacement therapy after neuropathy onset provides therapeutic benefit in a model of CMT1X
    Kagiava, A.
    Richter, J.
    Tryfonos, C.
    Karaiskos, C.
    Heslegrave, A. J.
    Sargiannidou, I
    Rossor, A. M.
    Zetterberg, H.
    Reilly, M. M.
    Christodoulou, C.
    Kleopa, K. A.
    HUMAN MOLECULAR GENETICS, 2019, 28 (21) : 3528 - 3542
  • [6] Gene therapy, CMT1X, and the inherited neuropathies
    Shy, Michael E.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2016, 113 (17) : 4552 - 4554
  • [7] AXONAL DEGENERATION IN MOUSE MODELS OF CMT1X NEUROPATHY
    Sargiannidou, I
    Vavlitou, N.
    Markoullis, K.
    Kyriacou, K.
    Scherer, S. S.
    Kleopa, K. A.
    GLIA, 2009, 57 (13) : S118 - S118
  • [8] AAV9 gene replacement therapy in two mutant mouse models of CMT1X demyelinating neuropathy
    Kagiava, Alexia
    Karaiskos, Christos
    Lapathitis, George
    Sargiannidou, Irene
    Bosch, Assumpcio
    Kleopa, Kleopas
    JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2021, 26 (03) : 327 - 327
  • [9] AAV9 gene replacement therapy in two mutant mouse models of CMT1X demyelinating neuropathy
    Kagiava, A.
    Karaiskos, C.
    Lapathitis, G.
    Sargiannidou, I.
    Bosch, A.
    Kleopa, K. A.
    HUMAN GENE THERAPY, 2021, 32 (19-20) : A121 - A122
  • [10] Gene replacement therapy in two Golgi-retained CMT1X mutants before and after the onset of demyelinating neuropathy
    Kagiava, Alexia
    Karaiskos, Christos
    Lapathitis, George
    Heslegrave, Amanda
    Sargiannidou, Irene
    Zetterberg, Henrik
    Bosch, Assumpcio
    Kleopa, Kleopas A.
    MOLECULAR THERAPY METHODS & CLINICAL DEVELOPMENT, 2023, 30 : 377 - 393
12345